Literature DB >> 16530120

Palliation of malignant ascites.

Stefanie M Rosenberg1.   

Abstract

The management of recurrent, symptomatic malignant ascites can be problematic for physicians and patients. The most common, low-risk method is large-volume paracentesis. Patient disease progression often leads to rapid reaccumulation of ascites, which requires frequent return visits to the hospital for symptom management. Other techniques have been developed to achieve palliation of symptoms, including tunneled external drainage catheters, peritoneal ports, and peritoneovenous

Entities:  

Mesh:

Year:  2006        PMID: 16530120     DOI: 10.1016/j.gtc.2005.12.006

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  20 in total

1.  Central venous pressure catheter for large-volume paracentesis in refractory ascites.

Authors:  Shahram Agah; Sahar Tavakoli; Hajar Nikbakht; Mehrdokht Najafi; Abdolreza Al-Agha
Journal:  Indian J Gastroenterol       Date:  2014-04-24

2.  The role of ascitic fluid viscosity in the differential diagnosis of ascites.

Authors:  Huseyin Savas Gokturk; Mehmet Demir; Nevin Akcaer Ozturk; Gulhan Kanat Unler; Sevsen Kulaksizoglu; Ilknur Kozanoglu; Ender Serin; Ugur Yilmaz
Journal:  Can J Gastroenterol       Date:  2010-04       Impact factor: 3.522

3.  A survey of treatment approaches of malignant ascites in Germany and Austria.

Authors:  C F Jehn; S Küpferling; G Oskay-Özcelik; D Lüftner
Journal:  Support Care Cancer       Date:  2014-12-21       Impact factor: 3.603

4.  Percutaneous management of malignant fluid collections.

Authors:  Leann S Stokes
Journal:  Semin Intervent Radiol       Date:  2007-12       Impact factor: 1.513

5.  Palliative treatment of malignant ascites: profile of catumaxomab.

Authors:  Lila Ammouri; Eric E Prommer
Journal:  Biologics       Date:  2010-05-25

Review 6.  Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review.

Authors:  Filippo Bellati; Chiara Napoletano; Ilary Ruscito; Maria Pastore; Milena Pernice; Morena Antonilli; Marianna Nuti; Pierluigi Benedetti Panici
Journal:  Invest New Drugs       Date:  2009-11-24       Impact factor: 3.850

Review 7.  Management of ascites.

Authors:  Fedja A Rochling; Rowen K Zetterman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Peritoneal catheter for continuous drainage of ascites in advanced cancer patients.

Authors:  Sebastiano Mercadante; Giuseppe Intravaia; Patrizia Ferrera; Patrizia Villari; Fabrizio David
Journal:  Support Care Cancer       Date:  2008-05-01       Impact factor: 3.603

9.  Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.

Authors:  Angel Mier Hicks; Joanne Chou; Marinela Capanu; Maeve A Lowery; Kenneth H Yu; Eileen M O'Reilly
Journal:  Clin Colorectal Cancer       Date:  2016-05-07       Impact factor: 4.481

10.  [Methods of symptom control in malignant ascites].

Authors:  Astrid Bodisch; Christian Muschitz; Meinolf Karthaus
Journal:  Wien Med Wochenschr       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.